Kroger Specialty Infusion is proud to announce it is now dispensing Xembify®, a 20% immune globulin indicated for treatment of primary humoral immunodeficiency disease (PIDD) in patients 2 years of age and older.
Primary Immunodeficiency Diseases (PIDD) are a group of more than 400 hereditary immunodeficiency disorders, that stem from a defect in the body’s immune system. With a weakened immune system PIDD patients are at high risk for infections and at deeper risk for developing chronic infections that impact quality of life.
XEMBIFY® (immune globulin subcutaneous human–klhw) 20% immune globulin is manufactured with a unique formulary to help protect a wide range of PIDD patients. The maximum potency of Xembify® protects patents from infections and the maximum purity demonstrates tolerability with mild to moderate local and systemic reactions.
Danny Singh, SVP of Operations for Kroger Specialty Infusion recently shared what it means to the PIDD community to have access to Xembify. “Helping people live healthier lives is our mission at Kroger Specialty Infusion, and having the ability to support the PI community with a complete portfolio of Immune Globulin therapy offering plays an important role in that mission. We are proud to add Xembify® to our treatment options for patients living with this chronic disease.”
In every instance at Kroger Specialty Infusion, you can expect dedicated Ig clinical teams, access to limited distribution medications, simple patient enrollment, experts in complex insurance management, comprehensive financial services, and personalized patient care support.
For more information or questions about Xembify®, please contact our dedicated Ig team at 866.202.9552 or by sending a message.
About Kroger Specialty Infusion:
Kroger Specialty Infusion is a specialized home infusion provider for Subcutaneous Immune Globulin (SCIG) and IV Immune Globulin (Ig) for autoimmune and primary immune deficiency diseases. We provide an individualized care plan to ensure each patient achieves an optimal treatment outcome within a safe environment in their home, our infusion suite, and the physicians' office. Our focused approach to disease management, along with our expertise in complex illnesses, allows us to offer a range of therapeutic medications and treatments. We are also a leading provider of plasma therapies. For more information, visit www.krogerspecialtyinfusion.com.
About Kroger Specialty Pharmacy:
At Kroger Specialty Pharmacy, our mission is to be the preferred pharmacy for people undergoing complex medication therapies by optimizing clinical outcomes and providing a high-touch, caring experience. As one of the nation's leading specialty pharmacies, Kroger Specialty Pharmacy offers comprehensive therapy-management programs as well as injectable and oral pharmaceutical treatments for Dermatology, HIV, Hepatitis C, Oncology, Multiple Sclerosis, Rheumatoid Arthritis, Growth Hormone Deficiency, Hunters Syndrome, Hemophilia, IVIG, HAE plus others. Kroger Specialty Pharmacy services patients in all 50 states and Puerto Rico and is ACHC and URAC Accredited in numerous sites. Kroger Specialty Pharmacy's clinically effective and cost-efficient therapy management programs provide direct value to healthcare organizations nationwide. We blend a high-touch, caring patient experience with specialized clinical knowledge, personalized care programs, and administrative expertise. For more information, www.krogerspecialtypharmacy.com.
Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world. We are an industry leader in producing plasma-derived medicines and transfusion medicine. Our business is organized into four divisions: Bioscience, Diagnostic, Hospital and Bio Supplies. We sell our products and services in more than 100 countries and regions and have subsidiaries in 30 of them. We aim to be a global leader in our markets and an industry reference for quality, safety and innovation. For more information, visit www.grifols.com or learn more about Xembify® at www.xembify.com.